SCHEMBL29283741

SCHEMBL29283741

CC(C)(C)OC(=O)N1CCC[C@H](Nc2ncc(C(F)(F)F)c(-c3cn(C(=O)OC(C)(C)C)c4ncccc34)n2)C1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 1/20 0.49
▸ CDK7 P50613 8/20 0.47
▸ CCNH P51946 8/20 0.47
▸ MNAT1 P51948 8/20 0.47
▸ MAPK3 P27361 6/20 0.45
▸ CCNK O75909 6/20 0.45
▸ CDK2 P24941 5/20 0.45
▸ CCNA2 P20248 1/20 0.45
▸ CDK13 Q14004 1/20 0.45
▸ CDK12 Q9NYV4 5/20 0.44
▸ CCNT1 O60563 4/20 0.44
▸ CDK9 P50750 4/20 0.44
▸ CCNE1 P24864 4/20 0.44
▸ CCNB2 O95067 1/20 0.44
▸ CDK1 P06493 1/20 0.44
▸ CCNB1 P14635 1/20 0.44
▸ CCNB3 Q8WWL7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29283742 1.00 TRPV1 (0.49) TRPV1CDK7CCNHMNAT1MAPK3
SCHEMBL29283727 0.90 CDK7 (0.46) TRPV1CDK7CCNHMNAT1MAPK3
SCHEMBL29283724 0.90 CDK7 (0.46) TRPV1CDK7CCNHMNAT1MAPK3
SCHEMBL29283744 0.89 CDK7 (0.45) TRPV1CDK7CCNHMNAT1MAPK3
SCHEMBL29283728 0.89 CDK7 (0.45) TRPV1CDK7CCNHMNAT1MAPK3
SCHEMBL29283725 0.89 CDK7 (0.45) TRPV1CDK7CCNHMNAT1MAPK3
SCHEMBL29283745 0.89 CDK7 (0.45) TRPV1CDK7CCNHMNAT1MAPK3
SCHEMBL21188533 0.87 CDK2 (0.53) TRPV1CDK7CCNHMNAT1CCNK
SCHEMBL29749300 0.87 CDK2 (0.53) TRPV1CDK7CCNHMNAT1CCNK
SCHEMBL29083554 0.87 CDK2 (0.53) TRPV1CDK7CCNHMNAT1CCNK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118176189-A Pyrimidine derivative, preparation method and application thereof 成都苑东生物制药股份有限公司 2024-06-11 — — CN disclosed
Send feedback